Search results
Results From The WOW.Com Content Network
DEA lawsuit NO. 20-71433, the Ninth Circuit dismissed a petition that asked the court to review the DEA's denial of a letter that requested the agency reschedule marijuana. Under the CSA, the DEA must begin investigating the rescheduling of a drug after receiving a petition by from any interested party, including the manufacturer of a drug, a ...
In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would ...
The change from Schedule I to Schedule III is welcome, but removing it from the schedules altogether is the best option.
Rep. Andy Harris, R-Md.-1st, is taking aim at federal efforts to lower the drug designation of marijuana as a schedule 1 substance to a schedule 3 on par with Tylenol with codeine.
Hemp Industries Association v. Drug Enforcement Administration, often shortened to HIA v. DEA, refers to two lawsuits concerning the legality of cannabis extracts and other products from the hemp plant that have very low or nonexistent natural THC levels, including CBD oil, in the United States. The first is from 2004 and the second is from 2018.
The proposal is to move marijuana from a Schedule I drug, along with heroin and LSD, to Schedule III, where it would join ketamine and anabolic steroids. ... A formal hearing is set for 9:30 a.m ...
The Single Convention is the main international treaty related to Cannabis sativa L. and its products.In its Article 1, the Single Convention defines "cannabis" as the "flowering or fruiting tops of the cannabis plant (excluding the seeds and leaves when not accompanied by the tops) from which the resin has not been extracted, by whatever name they may be designated;" while "cannabis resin" is ...
The Department of Health and Human Services says marijuana should no longer be classified alongside drugs like heroin and LSD. U.S. health agency recommends easing federal restrictions on ...